RT Journal Article
SR Electronic
T1 Identification of biological correlates associated with respiratory failure in COVID-19
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.09.29.20204289
DO 10.1101/2020.09.29.20204289
A1 Oh, Jung Hun
A1 Tannenbaum, Allen
A1 Deasy, Joseph O
YR 2020
UL http://medrxiv.org/content/early/2020/09/30/2020.09.29.20204289.abstract
AB Background Coronavirus disease 2019 (COVID-19) is a global public health concern. Recently, a genome-wide association study (GWAS) was performed with participants recruited from Italy and Spain by an international consortium group.Methods Summary GWAS statistics for 1610 patients with COVID-19 respiratory failure and 2205 controls were downloaded. In the current study, we analyzed the summary statistics with the information of loci and p-values for 8,582,968 single-nucleotide polymorphisms (SNPs), using gene ontology analysis to determine the top biological processes implicated in respiratory failure in COVID-19 patients.Results We considered the top 708 SNPs, using a p-value cutoff of 5×10−5, which were mapped to the nearest genes, leading to 144 unique genes. The list of genes was input into a curated database to conduct gene ontology and protein-protein interaction (PPI) analyses. The top ranked biological processes were wound healing, epithelial structure maintenance, muscle system processes, and cardiac-relevant biological processes with a false discovery rate < 0.05. In the PPI analysis, the largest connected network consisted of 8 genes. Through literature search, 7 out of the 8 genes were found to be implicated in both pulmonary and cardiac diseases.Conclusion Gene ontology and protein-protein interaction analyses identified cardio-pulmonary processes that may partially explain the risk of respiratory failure in COVID-19 patients.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research was funded in part through the NIH/NCI Cancer Center Support Grant P30 CA008748 and R21 CA234752.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Not Applicable.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll the data analyzed in this study are available at http://www.c19-genetics.eu. http://www.c19-genetics.eu